All Stories

  1. Unveiling the Algorithm: The Role of Explainable Artificial Intelligence in Modern Surgery
  2. Predictors of lung entrapment in malignant pleural effusion
  3. Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors
  4. Unresectable stage III non-small cell lung cancer: Insights from a Portuguese expert panel
  5. Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries
  6. Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer
  7. Improving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel
  8. O Impacto da Terapêutica Moduladora da CFTR na Infeção Pulmonar Crónica em Doentes com Fibrose Quística
  9. Endobronchial hamartoma – A 10-year retrospective analyses of bronchoscopy treatment
  10. Liquid biopsy in the management of advanced lung cancer: Implementation and practical aspects
  11. Immunotherapy in metastatic non-small cell lung cancer: EPSILoN as a prognostic score
  12. Portuguese Consensus Recommendations for Next-Generation Sequencing of Lung Cancer, Rare Tumors, and Cancers of Unknown Primary Origin in Clinical Practice
  13. Circulating lncRNA- and miRNA-Associated ceRNA Network as a Potential Prognostic Biomarker for Non-Hodgkin Lymphoma: A Bioinformatics Analysis and a Pilot Study
  14. Nanotechnology-Based Delivery Systems For Tyrosine Kinases Inhibitors In Non-Small Cell Lung Cancer Treatment
  15. Resistance to EGFR inhibitors in lung cancer occurs through horizontal transfer and is associated with increased caveolins expression
  16. A multicentric analysis of prognostic factors in malignant pleural mesothelioma
  17. Liquid Biopsy: the Value of Different Bodily Fluids
  18. ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort
  19. Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives
  20. miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin’s Lymphoma: Moving towards an RNA-Guided Precision Medicine
  21. The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management
  22. Enlightening clinical and therapeutic heterogeneity in thoracic actinomycosis: A review in bronchiectasis and non-bronchiectasis patients
  23. Predictors of survival and technical success of bronchoscopic interventions in malignant airway obstruction
  24. Airway stents in malignant central airway obstruction
  25. The role of interventional bronchoscopy in the management of post-intubation tracheal stenosis: A 20-year experience
  26. Liquid Biopsy for Disease Monitoring in Non-Small Cell Lung Cancer: The Link between Biology and the Clinic
  27. Management of Coronavirus Disease 2019 Patients With Lung Cancer: Experience From a Thoracic Oncology Center
  28. COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
  29. Clinical Application of Next-Generation Sequencing of Plasma Cell-Free DNA for Genotyping Untreated Advanced Non-Small Cell Lung Cancer
  30. Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer
  31. Modified Glasgow Prognostic Score predicts survival among advanced non-small cell lung carcinoma patients treated with anti-PD1 agents
  32. Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients
  33. The opportunistic effect of exosomes on Non-Hodgkin Lymphoma microenvironment modulation
  34. RAD52 Functions in Homologous Recombination and Its Importance on Genomic Integrity Maintenance and Cancer Therapy
  35. Mutational status of advanced lung adenocarcinoma in a Portuguese cohort
  36. Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer
  37. Negative predictive value of lung cancer staging by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
  38. Fatal encephalopathy after pembrolizumab treatment for advanced non-small cell lung carcinoma
  39. Treatment of advanced EGFR-mutant NSCLC patients: Sequencing matters
  40. Role of Bronchoscopic Techniques in the Diagnosis of Thoracic Sarcoidosis
  41. Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation
  42. Lung adenocarcinoma with miliary metastases mimicking disseminated tuberculosis
  43. Expression of microRNAs 16, 20a, 150 and 155 in anal squamous intraepithelial lesions from high-risk groups
  44. Circulating Tumor DNA: A Step into the Future of Cancer Management
  45. Endobronchial Ultrasound under Moderate Sedation versus General Anesthesia
  46. Lung cancer in pregnancy – Report of a case treated with crizotinib
  47. Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population
  48. Expression profile of microRNA-146a along HPV-induced multistep carcinogenesis: a study in HPV16 transgenic mice
  49. The role of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of lymphoproliferative disorders
  50. Plasmatic miR-210, miR-221 and miR-1233 profile: potential liquid biopsies candidates for renal cell carcinoma
  51. Regulation of miRNA-146a and miRNA-150 Levels by Celecoxib in Premalignant Lesions of K14-HPV16 Mice
  52. Dysregulated expression of microRNA-150 in human papillomavirus-induced lesions of K14-HPV16 transgenic mice
  53. How to treat a glomus tumor of the airways?
  54. Tracheal lobular capillary hemangioma treated with laser photocoagulation
  55. Influence of emphysema distribution on pulmonary function parameters in COPD patients
  56. The value of rapid on-site evaluation during EBUS-TBNA
  57. EBUS in pulmonary sarcoidosis: What to expect?
  58. EBUS in pulmonary sarcoidosis: What to expect?
  59. Clinical challenges of persistent pulmonary air-leaks—Case report
  60. Sedação com midazolam na broncofibroscopia – estudo prospetivo
  61. Integrated PET/CT in non-small cell lung cancer staging—Clinical and pathological agreement
  62. Leiomioma endobrônquico primário – ressecção laser endoscópica
  63. Primary endobronchial leiomyoma – endoscopic laser resection
  64. Granulomatose de Wegener – Envolvimento otológico, nasal, laringotraqueal e pulmonar